Cargando…

Initial plasma levels of lipopolysaccharide binding protein are associated with severe sepsis in patients with community-acquired pneumonia

Detalles Bibliográficos
Autores principales:	Martino, ML, Krichevsky, A, He, S, Fine, J, Angus, DC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301477/ http://dx.doi.org/10.1186/cc1921

Ejemplares similares

Correlation between plasma peroxides and procalcitonin levels in patients with severe streptococcal community acquired pneumonia
por: Borrelli, E, et al.
Publicado: (2002)

An upper estimate of the attributable mortality and cost of severe sepsis in surgical patients
por: Linde-Zwirble, WT, et al.
Publicado: (2003)

Severe community acquired pneumonia and ARDS: prognostic factors in infants
por: Chidini, G, et al.
Publicado: (2003)

Racial disparities in quality of care in community-acquired pneumonia
por: Mayr, FB, et al.
Publicado: (2008)

The IL-10 -819T polymorphism is associated with increased susceptibility to severe sepsis
por: Wood, KA, et al.
Publicado: (2003)

Cost-effectiveness of early goal-directed therapy in the treatment of severe sepsis and septic shock
por: Huang, DT, et al.
Publicado: (2003)

Mathematical modeling of community-acquired pneumonia patients
por: Sarkar, J, et al.
Publicado: (2009)

Efficacy and safety of sequential IV/PO moxifloxacin for the treatment of severe community-acquired pneumonia
por: Lode, H, et al.
Publicado: (2002)

An alternative, and more sensitive, approach to detecting differences in outcome in sepsis
por: Wax, RS, et al.
Publicado: (2000)

Comparing Gray's and Cox models in sepsis survival
por: Kasal, J, et al.
Publicado: (2001)

Lipopolysaccharide binding protein: a poor parameter for the differentiation of SIRS and sepsis but useful as determinant of outcome in septic patients
por: Prucha, M, et al.
Publicado: (2002)

Coagulation in hospitalized community-acquired pneumonia: disturbances in even the least ill
por: Reade, MC, et al.
Publicado: (2008)

Predictors of Severe Sepsis among Patients Hospitalized for Community-Acquired Pneumonia
por: Montull, Beatriz, et al.
Publicado: (2016)

Plasma kallistatin levels in patients with severe community-acquired pneumonia
por: Lin, Wei-Chieh, et al.
Publicado: (2013)

Soluble RAGE as a severity marker in community acquired pneumonia associated sepsis
por: Narvaez-Rivera, Rodrigo M, et al.
Publicado: (2012)

Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study
por: Gaïni, Shahin, et al.
Publicado: (2006)

Vitamin D Level and Risk of Community-Acquired Pneumonia and Sepsis
por: Jovanovich, Anna J., et al.
Publicado: (2014)

Host-targeted approaches to sepsis due to community-acquired pneumonia
por: Cilloniz, Catia, et al.
Publicado: (2022)

Age-related differences of outcomes in patients hospitalized with community-acquired pneumonia are not explained by differences in immune response
por: Kale, S, et al.
Publicado: (2010)

Severe sepsis: international and specialty variations in initial management
por: Reade, MC, et al.
Publicado: (2008)

Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia
por: Suberviola, B, et al.
Publicado: (2011)

Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis
por: Aliberti, Stefano, et al.
Publicado: (2014)

Risk of readmission following admission with community-acquired sepsis to a medical emergency department - a follow up study
por: Henriksen, Daniel P, et al.
Publicado: (2015)

Pathogenesis of organ damage during sepsis. In vitro influence of lipopolysaccharides and cytokines on the microtubular system
por: Ruβwurm, S, et al.
Publicado: (1997)

Severe community-acquired pneumonia
por: Morgan, AJ, et al.
Publicado: (2016)

Severe Community-Acquired Pneumonia
por: Khatib, Khalid, et al.
Publicado: (2019)

Severe Community-Acquired Pneumonia
por: Sligl, Wendy I., et al.
Publicado: (2013)

Severe community-acquired pneumonia
por: Niederman, Michael S., et al.
Publicado: (2022)

Footprints of Sepsis Framed Within Community Acquired Pneumonia in the Blood Transcriptome
por: Hopp, Lydia, et al.
Publicado: (2018)

Identification of Immune-Related Genes in Sepsis due to Community-Acquired Pneumonia
por: Li, Yanyan, et al.
Publicado: (2021)

Lymphopenia Is Associated With Poor Outcomes of Patients With Community-Acquired Pneumonia and Sepsis
por: Cilloniz, Catia, et al.
Publicado: (2021)

Diagnostic performance of chest X-ray for the diagnosis of community acquired pneumonia in acute admitted patients with respiratory symptoms
por: Laursen, Christian B, et al.
Publicado: (2013)

Usefulness of Plasma YKL-40 in Management of Community-Acquired Pneumonia Severity in Patients
por: Wang, Hsiang-Ling, et al.
Publicado: (2013)

Usefulness of Plasma Procalcitonin to Predict Severity in Elderly Patients with Community-Acquired Pneumonia
por: Kim, Ji Hye, et al.
Publicado: (2013)

Cytokine Concentrations in Plasma from Children with Severe and Non-Severe Community Acquired Pneumonia
por: Haugen, Johanne, et al.
Publicado: (2015)

Heparin-Binding Protein in Critically Ill Children With Severe Community-Acquired Pneumonia
por: Huang, Caizhi, et al.
Publicado: (2021)

Prognostic Value of Plasma Presepsin and Pneumonia Severity Index in Patients with Community-Acquired Pneumonia in the Emergency Department
por: Lee, Kyeong-Ryong, et al.
Publicado: (2022)

Utility of Plasma Osteopontin Levels in Management of Community-Acquired Pneumonia
por: Chang, Jer-Hwa, et al.
Publicado: (2016)

Laboratory Investigations in Patients with Community Acquired Sepsis and/or Pneumonia Caused by Burkholderia pseudomallei
por: Behera, Bijayini, et al.
Publicado: (2022)

Advances in severe community-acquired pneumonia
por: Wang, Jian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8p1c6jo8787olpfsj5tci30oa8